Higher expression of CD158a and CD158b KIR receptors on tumor-infiltrating NK-cells that correlated with diminished NK-cell cytotoxicity and tumor progression has also been observed in patients with other solid tumors such as melanoma or non-small cell lung cancer22–24. This evidence concerns the gene KIR2DL1 and melanoma.